Alterations of cerebral glucose metabolism indicate progress to severe morphological brain lesions in neuropsychiatric systemic lupus erythematosus

Lupus

Volumn 9, Issue 5, 2000, Pages 386-389

  Weiner, S M ^a   Otte, A ^b   Schumacher, M ^a   Brink, I ^a   Juengling, F D ^a   Sobanksi, T ^a   Nitzsche, E U ^a   Peter, H H ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

F 18 fluoro 2 deoxy D glucose positron emission tomography (FDG PET); Magnetic resonance imaging (MRI); Neuropsychiatric; Systemic lupus erythematosus (SLE)

Indexed keywords

AMITRIPTYLINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUORODEOXYGLUCOSE F 18; GLUCOSE; LITHIUM CARBONATE; PREDNISONE;

ADULT; AMNESIA; ARTICLE; BASAL GANGLION; BRAIN INJURY; CASE REPORT; CAUDATE NUCLEUS; CONFUSION; CONTROLLED STUDY; DEPRESSION; EARLY DIAGNOSIS; FEMALE; FRONTAL LOBE; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HEADACHE; HUMAN; LEUKOPENIA; NEUROPSYCHIATRY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL CORTEX; PARIETAL LOBE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; SEIZURE; SYSTEMIC LUPUS ERYTHEMATOSUS; TEMPORAL CORTEX; VISUAL DISORDER;

EID: 0034045928     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120300678828370     Document Type: Article

References (13)

1. Otte A, Weiner SM, Peter HH et al. Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study. Eur J Nucl Med 1997; 24: 787-791.
2. Lin WY, Wang SJ, Yen TC, Lan JL. Technetium-99m-HMPAO brain SPECT in systemic lupus erythematosus with CNS involvement. J Nucl Med 1997; 38: 1112-1115.
3. Sibbitt WL Jr, Sibbett RR. Magnetic resonance spectroscopy and positron emission tomography scanning in neuropsychiatric systemic lupus erythematosus. Rheum Dis Clin North Am 1993; 19: 851-868.
4. Falcini F, De Cristofaro MT, Ermini M et al. Regional cerebral blood flow in juvenile systemic lupus erythematosus: a prospective SPECT study. J Rheumatol 1998; 25: 583-588.
5. Kao CH, Ho YJ, Lan JL et al. Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings. Arthritis Rheum 1999; 42: 61-68.
6. Otte A, Weiner SM, Hoegerle S et al. Neuropsychiatrie systemic lupus erythematosus before and after immunosuppressive treatment: a FDG PET study. Lupus 1998; 7: 57-59.
7. Hamacher K, Coenen HH, Stocklin G. Efficient stereospecific synthesis of no-carrier -added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986; 27: 235-238.
8. Stimmler MM, Coletti PM, Quismorio FP JR. Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus. Semin Arthritis Rheum 1993; 22: 335-349.
9. Kodama K, Okada S, Hino T et al. Single photon emission computed tomography in systemic lupus erythematosus with psychiatric symptoms. J Neurol Neurosurg Psychiatry 1995; 58. 307-311.
10. Weiner SM, Otte A, Schumacher M et al. Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET. Ann Rheum Dis 2000; in press.
11. Furie R, Ishikawa T, Dhawan V, Eidelberg D. Alternating hemichorea in primary antiphospholipid syndrome: evidence for contralateral striatal hypermetabolism. Neurology 1994; 44: 2197-2199.
12. Sundén-Cullberg J, Tedroff J, Aquilonius S-M. Reversible choreaMov Disord 1998; 13: 147-149.
13. Sibbitt WL, Brooks WM, Haseler LJ et al. Spin-spin relaxation of brain tissues in systemic lupus erythzematosus. Arthritis Rheum 1995; 38: 810-818.